Overview

Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease

Status:
Completed
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to better understand vitamin D catabolism and how it is affected by CKD and race.
Phase:
Phase 1
Details
Lead Sponsor:
University of Washington
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Calcifediol
Ergocalciferols
Hydroxycholecalciferols
Vitamin D
Vitamins